All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

Prevalence of Anemia among People Living with HIV/AIDS Starting Antiretroviral Therapy in the Era of Dolutegravir in Kinshasa, Democratic Republic of Congo

DOI: 10.4236/oalib.1109580, PP. 1-8

Subject Areas: HIV

Keywords: Anemia, PLHIV, Start of ART, Kinshasa

Full-Text   Cite this paper   Add to My Lib

Abstract

Background: Anemia remains the most frequent hematological complication during HIV/AIDS infection. Objective: The objective of this study was to determine the prevalence of anemia among People Living with HIV (PLHIV) who start AntiRetroViral treatment in Kinshasa in the era of Dolutegravir. Methods: This study was a descriptive cross-sectional study to determine the prevalence of anemia in PLHIV at the start of ARV Treatment (ART) in 13 Outpatient Treatment Centers (OTC) in Kinshasa. The patient inclusion period was from October 04, 2021 to February 15, 2022. Patients included in the present study were HIV type 1 infected, ART naïve, over the age of 18 and had signed informed consent for participation. The parameters of interest were: The hemoglobin level and the clinic of the patients. Results: One hundred and nineteen patients were included in this work with an average age of 39.87 ± 12.36 years and extremities of 18 to 69 years. The most represented age group is that of 36 to 45 years with 37 patients (31.9%). Sixty-seven patients (56.3%) are female. The average value for Hemoglobin is 10.30 ± 2.33 g/dl. The most represented range of values is that of more than 13 g/dl with 73 patients (69.5%). Forty-nine (49) patients, or 41.5%, were in clinical stage 3. Fifty-five (55) patients, or 47.0%, had normal clinical status. Conclusion: At the start of ART, 21.0% of patients presented with some form of anemia: 7.6% mild anemia, 8.6% moderate anemia and 4.8% severe anemia. About half of the patients (41.5%) were at clinical stage 3 according to WHO and more than half of all patients (47.0%) had a normal clinical condition.

Cite this paper

Ikolango, B. B. , Lusakibanza, M. , Kahunu, G. M. , Tsumbu, B. B. B. , Lunganza, R. K. and Ntambwe, E. K. (2023). Prevalence of Anemia among People Living with HIV/AIDS Starting Antiretroviral Therapy in the Era of Dolutegravir in Kinshasa, Democratic Republic of Congo. Open Access Library Journal, 10, e9580. doi: http://dx.doi.org/10.4236/oalib.1109580.

References

[1]  United Nations AIDS Program (UNAIDS) (2020) Country Factsheets: Democratic Republic of the Congo. https://www.unaids.org/en/regionscountries/countries/democraticrepublicofthecongo
[2]  Mocroft, A., Kirk, O., Barton, S.E., Dietrich, M., Proenca, R., Colebunders, R., Pradier, C., Arminio Monforte, A., Ledergerber, B. and Lundgren, J.D. (1999) Anaemia Is an Independent Predictive Marker for Clinical Prognosis in HIV-Infected Patients from across EUROPE. EuroSIDA Study Group. AIDS, 13, 943-950. https://doi.org/10.1097/00002030-199905280-00010
[3]  Losenga, O.L., Dikati, M.N., Bongenya, I.B., Ntumba, K.T., Booto, I.G., Dembo, D.R., Selenge, M.S., Nonga, E.J., Kabamba, A.C., Sombo, A.M.T., Bumoko, M.G. and Kamangu, N.E. (2022) Sociodemographic and Anthropometric Profile of People Living with Human Immunodeficiency Virus Starting Treatment in Kinshasa, Democratic Republic of the Congo. Open Access Library Journal, 9, e9056. https://doi.org/10.4236/oalib.1109056
[4]  Kamangu, N.E., Bulanda, I.B., Bongenia, I.B., Botomwito, T.H., Mvumbi, L.G., De Mol, P., Vaira, D., Hayette, M.-P. and Kalala, L.R. (2015) Virological Profile of Patients Infected with HIV Starting Antiretroviral Treatment in Kinshasa. Open Access Library Journal, 2, e1564. https://doi.org/10.4236/oalib.1101564
[5]  Mbula, M.M.K., Situakibanza, H.N.T., Mananga, L.G., Longokolo, M.M., Mandina, N.M., Mayasi, N.N., Mbula, M.M., Bepouka, B., Amaela, E.N., Tshilumba, D.N., Odio, O., Nkodila, A. and Longo Mbenza, B. (2020) Profil clinique et biologique des Personnes Vivant avec le VIH/SIDA suivies dans le Service des Maladies Infectieuses des Cliniques Universitaires de Kinshasa, République Démocratique du Congo. Revue Malienne d'Infectiologie et de Microbiologie, 15, 21-29.
[6]  Kamangu, N.E., Wumba, R.D.M., Situakibanza, H.N.T., Lukusa, P.T., Kapend, L.K., Mvumbi, G.L., Hayette, M.P. and Kalala, R.L. (2018) Molecular Epidemiology of Human Immunodeficiency Virus Type 1 and Therapeutic Monitoring of Patients Treated in Kinshasa/Democratic Republic of the Congo. International Journal of HIV and AIDS Research, 2, 6-11.
[7]  Attinsounon, C.A., Dovonou, C.A., Alassani, C.A., Gomina, M., Agbodande, K.A., Wanvoegbe, F.A., Bokpe, R., Ahanhanzo-Glele, R., Azon-Kouanou, A. and Zannou, D.M. (2017) Prévalence et facteurs associes a l’anémie chez les adultes infectés par le VIH a l’initiation du traitement antirétroviral. Médecine et Maladies Infectieuses, 47, S135-S136. https://doi.org/10.1016/j.medmal.2017.03.327

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413